50 employees
Proneuron Biotechnologies develops spinal cord injury treatments, researches cures for paralysis, and neurological therapies.
1996
$10M
from 3 investors over 3 rounds
Proneuron Biotechnologies, Inc. raised $10M on December 31, 2001
Investors: Giza Venture Capital, Teva UK Limited and Pitango Venture Capital